» Articles » PMID: 30484954

Exosomes from Mesenchymal Stem Cells Expressing MiR-125b Inhibit Neointimal Hyperplasia Via Myosin IE

Overview
Journal J Cell Mol Med
Date 2018 Nov 29
PMID 30484954
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Intercellular communication between mesenchymal stem cells (MSCs) and their target cells in the perivascular environment is modulated by exosomes derived from MSCs. However, the potential role of exosome-mediated microRNA transfer in neointimal hyperplasia remains to be investigated. To evaluate the effects of MSC-derived exosomes (MSC-Exo) on neointimal hyperplasia, their effects upon vascular smooth muscle cell (VSMC) growth in vitro and neointimal hyperplasia in vivo were assessed in a model of balloon-induced vascular injury. Our results showed that MSC-Exo were internalised by VSMCs and inhibited proliferation and migration in vitro. Further analysis revealed that miR-125b was enriched in MSC-Exo, and repressed the expression of myosin 1E (Myo1e) by targeting its 3' untranslated region. Additionally, MSC-Exo and exosomally transferred miR-125b repressed Myo1e expression and suppressed VSMC proliferation and migration and neointimal hyperplasia in vivo. In summary, our findings revealed that MSC-Exo can transfer miR-125b to VSMCs and inhibit VSMC proliferation and migration in vitro and neointimal hyperplasia in vivo by repressing Myo1e, indicating that miR-125b may be a therapeutic target in the treatment of vascular diseases.

Citing Articles

Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy.

Jiang Y, Wei Z, Song Z, Yu M, Huang J, Qian H Drug Deliv Transl Res. 2025; .

PMID: 39873880 DOI: 10.1007/s13346-025-01792-1.


Exosome miR-199a-5p modulated vascular remodeling and inflammatory infiltration of Takayasu's arteritis.

Guo S, Li J, Pang S, Li J, Tian X Arthritis Res Ther. 2025; 27(1):11.

PMID: 39833857 PMC: 11744942. DOI: 10.1186/s13075-025-03475-1.


Hyaluronic acid: An overlooked extracellular vesicle contaminant.

Goncalves J, Ghebosu R, Tan X, Iannotta D, Koifman N, Wolfram J J Extracell Vesicles. 2023; 12(9):e12362.

PMID: 37712345 PMC: 10502654. DOI: 10.1002/jev2.12362.


Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Vasculopathies and Angiogenesis: Therapeutic Applications and Optimization.

Zhu Y, Liao Z, Mo M, Xiong X Biomolecules. 2023; 13(7).

PMID: 37509145 PMC: 10377109. DOI: 10.3390/biom13071109.


Mesenchymal Stem Cell-Derived Extracellular Vesicles: Hype or Hope for Skeletal Muscle Anti-Frailty.

Mahindran E, Wan Kamarul Zaman W, Ahmad Amin Noordin K, Tan Y, Nordin F Int J Mol Sci. 2023; 24(9).

PMID: 37175537 PMC: 10178115. DOI: 10.3390/ijms24097833.


References
1.
Curcio A, Torella D, Indolfi C . Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011; 75(6):1287-96. DOI: 10.1253/circj.cj-11-0366. View

2.
Ju X, Zou H, Liu K, Duan J, Li S, Zhou Z . Meta-analysis of the effect of mesenchymal stem cell transplantation on vascular remodeling after carotid balloon injury in animal models. PLoS One. 2015; 10(3):e0120082. PMC: 4374727. DOI: 10.1371/journal.pone.0120082. View

3.
Lee C, Mitsialis S, Aslam M, Vitali S, Vergadi E, Konstantinou G . Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012; 126(22):2601-11. PMC: 3979353. DOI: 10.1161/CIRCULATIONAHA.112.114173. View

4.
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H . MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007; 100(11):1579-88. DOI: 10.1161/CIRCRESAHA.106.141986. View

5.
Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C . A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009; 104(4):476-87. PMC: 2728290. DOI: 10.1161/CIRCRESAHA.108.185363. View